• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effect of age upon the affinity of microsomal mono-oxygenase enzymes for substrate in human liver.

作者信息

Wynne H A, Mutch E, James O F, Wright P, Rawlins M D, Woodhouse K W

机构信息

Department of Medicine (Geriatrics), University of Newcastle upon Tyne.

出版信息

Age Ageing. 1988 Nov;17(6):401-5. doi: 10.1093/ageing/17.6.401.

DOI:10.1093/ageing/17.6.401
PMID:3266441
Abstract

Although the clearance of many oxidized drugs falls with age, a corresponding fall in the maximal activities of drug metabolizing enzymes has not been noted. The possibility of a fall in enzyme affinity for substrate with age, which could account for the observed changes, has not previously been investigated in human liver. We have studied the kinetics of the microsomal mono-oxygenase 7-ethoxycoumarin-O-de-ethylase in 17 human liver biopsy specimens. No correlation was observed between age and microsomal protein recovery, maximal enzyme activity or apparent enzyme affinity. Since microsomal mono-oxygenase activities and affinities appear not to change in human liver, other factors such as a fall in liver volume or blood flow must be responsible for the decline in clearance of many oxidized drugs which occurs with ageing.

摘要

相似文献

1
The effect of age upon the affinity of microsomal mono-oxygenase enzymes for substrate in human liver.
Age Ageing. 1988 Nov;17(6):401-5. doi: 10.1093/ageing/17.6.401.
2
The effect of age on mono-oxygenase enzyme kinetics in rat liver microsomes.年龄对大鼠肝微粒体中单加氧酶酶动力学的影响。
Age Ageing. 1987 May;16(3):153-8. doi: 10.1093/ageing/16.3.153.
3
The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver.
Eur J Clin Pharmacol. 1984;26(1):61-4. doi: 10.1007/BF00546710.
4
The effect of age on pathways of drug metabolism in human liver.
Age Ageing. 1984 Nov;13(6):328-34. doi: 10.1093/ageing/13.6.328.
5
The effect of alcoholic cirrhosis on the activities of microsomal aldrin epoxidase, 7-ethoxycoumarin O-de-ethylase and epoxide hydrolase, and on the concentrations of reduced glutathione in human liver.酒精性肝硬化对人肝脏微粒体艾氏剂环氧化酶、7-乙氧基香豆素O-脱乙基酶和环氧化物水解酶活性以及还原型谷胱甘肽浓度的影响。
Br J Clin Pharmacol. 1983 Jun;15(6):667-72. doi: 10.1111/j.1365-2125.1983.tb01547.x.
6
7-Ethoxycoumarin dealkylase and cytochrome P-450 from grey partridge (Perdix perdix) hepatic and duodenal microsomes.
Biochem Biophys Res Commun. 1980 Nov 28;97(2):546-52. doi: 10.1016/0006-291x(80)90298-3.
7
Effect of tamoxifen treatment on liver, lung and intestinal mixed-function oxidases in male and female rats.
Drug Metab Dispos. 1981 Jul-Aug;9(4):327-30.
8
Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.莫罗他辛对大鼠肝脏微粒体中药物代谢酶活性的影响。
Arzneimittelforschung. 1988 Jul;38(7A):1019-22.
9
Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice.重组肿瘤坏死因子可抑制小鼠细胞色素P450依赖性微粒体药物代谢。
Biochem Biophys Res Commun. 1986 Apr 14;136(1):316-21. doi: 10.1016/0006-291x(86)90912-5.
10
Enhancement of hepatic drug biotransformation by a short-term intermittent turpentine exposure in the rat.大鼠短期间歇性接触松节油对肝脏药物生物转化的增强作用。
Acta Pharmacol Toxicol (Copenh). 1980 Jan;46(1):32-36. doi: 10.1111/j.1600-0773.1980.tb02415.x.

引用本文的文献

1
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach.应用基于生理的药代动力学方法建立不同 CYP2D6 表型人群中利培酮及其 9-羟基代谢物药代动力学的年龄相关性变化模型。
Pharm Res. 2020 May 31;37(6):110. doi: 10.1007/s11095-020-02843-7.
2
Cirrhotic patients and older people.肝硬化患者和老年人。
World J Hepatol. 2019 Sep 27;11(9):663-677. doi: 10.4254/wjh.v11.i9.663.
3
Perioperative management of delirium and dementia in the geriatric surgical patient.
老年外科患者谵妄和痴呆的围手术期管理。
Langenbecks Arch Surg. 2013 Oct;398(7):947-55. doi: 10.1007/s00423-013-1102-5. Epub 2013 Aug 24.
4
Population pharmacokinetic modelling of roflumilast and roflumilast N-oxide by total phosphodiesterase-4 inhibitory activity and development of a population pharmacodynamic-adverse event model.罗氟司特及其 N-氧化物的群体药代动力学模型:基于总磷酸二酯酶-4 抑制活性和群体药效-不良事件模型的建立。
Clin Pharmacokinet. 2010 Sep;49(9):589-606. doi: 10.2165/11536600-000000000-00000.
5
Drug dosage in the elderly: dermatological drugs.老年人的药物剂量:皮肤科药物
Drugs Aging. 2006;23(3):203-15. doi: 10.2165/00002512-200623030-00003.
6
Predicting and preventing adverse drug reactions in the very old.预测和预防高龄患者的药物不良反应
Drugs Aging. 2005;22(5):375-92. doi: 10.2165/00002512-200522050-00003.
7
Liver function and phase I drug metabolism in the elderly: a paradox.老年人的肝功能与I期药物代谢:一个悖论。
Drugs Aging. 2001;18(11):837-51. doi: 10.2165/00002512-200118110-00005.
8
Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?老年人的药代动力学变化。它们会导致药物滥用和依赖吗?
Clin Pharmacokinet. 1996 Nov;31(5):372-85. doi: 10.2165/00003088-199631050-00004.
9
The influence of age, liver size and enantiomer concentrations on warfarin requirements.年龄、肝脏大小和对映体浓度对华法林需求量的影响。
Br J Clin Pharmacol. 1995 Sep;40(3):203-7.
10
Age-related changes in the gastrointestinal system. Effects on drug therapy.胃肠道系统的年龄相关变化。对药物治疗的影响。
Drugs Aging. 1994 Jul;5(1):34-48. doi: 10.2165/00002512-199405010-00004.